References
- Braman SS. The Global Burden of Asthma. Chest. 2006;130(1 Suppl):4S–12S. doi:https://doi.org/10.1378/chest.130.1_suppl.4S.
- Centers for Disease Control and Prevention. Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001–2009. MMWR Morb Mortal Wkly Rep. 2011;60(17):547–552. [cited Oct 10]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21544044
- Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326(8):501–506. doi:https://doi.org/10.1056/NEJM199202203260801.
- Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277(11):887–891. doi:https://doi.org/10.1001/jama.1997.03540350037030.
- Schatz M, Zeiger RS, Vollmer WM, Mosen D, Apter AJ, Stibolt TB, Leong A, Johnson MS, Mendoza G, Cook EF, et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol. 2006;117(5):995–1000. doi:https://doi.org/10.1016/j.jaci.2006.01.053.
- Ernst P, Habbick B, Suissa S, Hemmelgarn B, Cockcroft D, Buist AS, Horwitz RI, McNutt M, Spitzer WO. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993;148(1):75–79. doi:https://doi.org/10.1164/ajrccm/148.1.75.
- Eisner MD, Lieu TA, Chi F, Capra AM, Mendoza GR, Selby JV, Blanc PD. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J. 2001;17(2):233–240. doi:https://doi.org/10.1183/09031936.01.17202330.
- Schatz M, Zeiger RS, Yang S-JT, Chen W, Crawford WW, Sajjan SG, Allen-Ramey F. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Am J Manag Care. 2010;16(5):327–333. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20469953
- Schatz M, Zeiger RS. Improving asthma outcomes in large populations. J Allergy Clin Immunol. 2011;128(2):273–277. doi:https://doi.org/10.1016/j.jaci.2011.03.027.
- Fuhlbrigge A, Carey VJ, Adams RJ, et al. Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care. 2004;42(5):465–471.
- Griffiths C, Naish J, Sturdy P, Pereira F. Prescribing and hospital admissions for asthma in east London. BMJ. 1996;312(7029):481–482. doi:https://doi.org/10.1136/bmj.312.7029.481.
- Schatz M, Zeiger RS, Vollmer WM, Mosen D, Mendoza G, Apter AJ, Stibolt TB, Leong A, Johnson MS, Cook EF, et al. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest. 2006;130(1):43–50. doi:https://doi.org/10.1378/chest.130.1.43.
- Schatz M, Stempel D. Asthma quality-of-care measures using administrative data: relationships to subsequent exacerbations in multiple databases. Ann Allergy Asthma Immunol. 2008;101(3):235–239. doi:https://doi.org/10.1016/S1081-1206(10)60487-5.
- Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest. 2005;128(4):1968–1973. doi:https://doi.org/10.1378/chest.128.4.1968.
- Yong PL, Werner RM. Process quality measures and asthma exacerbations in the medicaid population. J Allergy Clin Immunol. 2009; 124(5):961–966. doi:https://doi.org/10.1016/j.jaci.2009.07.027.
- McKibben S, De Simoni A, Bush A, Thomas M, Griffiths C. The use of electronic alerts in primary care computer systems to identify the excessive prescription of short-acting beta 2 -agonists for people with asthma: A systematic review. Npj Prim Care Respir Med. 2018;28(1):14.
- Shlomi D, Katz I, Segel MJ, Oberman B, Peled N. Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase. J Asthma. 2018;55(5):571–577. doi:https://doi.org/10.1080/02770903.2017.1348513.
- GINA Report, Global Strategy for Asthma Management and Prevention | Documents/Resources | GINA [Internet]. [cited 2015 Oct 30]. Available from: http://www.ginasthma.org/documents/4.
- Partridge MR, van der Molen T, Myrseth S-E, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6(1):13. doi:https://doi.org/10.1186/1471-2466-6-13.
- Boulet L-P, Phillips R, O'Byrne P, Becker A. Evaluation of asthma control by physicians and patients: Comparison with current guidelines. Can Respir J. 2002;9(6):417–423. doi:https://doi.org/10.1155/2002/731804.
- Urrutia I, Plaza V, Pascual S. Asthma control and concordance of opinion1. Laforest L, Licaj I, Devouas1. Laforest L, Licaj I, Devouassoux G, et al. Relative exposure to controller therapy and asthma exacerbations: a validation study in community pharmacies. Pharmacoepidemiol Drug Saf. Jo1 Laforest L, Licaj I, Devouassoux G, al Relat Expo to Controll Ther asthma exacerbations a Valid study community. Pharm Pharmacoepidemiol Drug Saf. 2014;23(9):958–964. 2013;50(8):877–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23808796
- Prieto L, Badiola C, Villa JR, Plaza V, Molina J, Cimas E. Asthma control: do patients' and physicians' opinions fit in with patients' asthma control status? J Asthma. 2007;44(6):461–467. doi:https://doi.org/10.1080/02770900701421989.
- Chapman KR, Hinds D, Piazza P, Raherison C, Gibbs M, Greulich T, Gaalswyk K, Lin J, Adachi M, Davis KJ, et al. Physician perspectives on the burden and management of asthma in six countries: The Global Asthma Physician Survey (GAPS). BMC Pulm Med. 2017;17(1):153. doi:https://doi.org/10.1186/s12890-017-0492-5.
- Tavakoli H, Mark FitzGerald J, Lynd LD, Sadatsafavi M. Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study. BMC Pulm Med. 2018;18(1):33 doi:https://doi.org/10.1186/s12890-018-0598-4.